Kytopen, a biotechnology company that develops and markets advanced cell engineering solutions, appointed Michael Chiu, Chief Executive Officer. An entrepreneurial leader with extensive experience in building and commercializing new technologies, Chiu brings a proven track record in fundraising, product development, and marketing launches. Chiu succeeds Paulo Garcia, one of the company’s co-founders, who will continue as an advisor. Chiu joins Kytopen at the time of its accelerated roll...